Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.
about
Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patientsCan the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-AnalysisInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisNeutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapyPrognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinomaStudy of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes.Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyPrognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive modelNeutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer.Prognostic value of neutrophil to lymphocyte ratio for gastric cancer.Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysisPrognostic value of neutrophil distribution in cholangiocarcinoma.Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancerA comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer.The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection.Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancerPretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancerPrognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer.Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.Gender differences and age-specific associations between body mass index and other cardiovascular risk factors in CMV infected and uninfected people.Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsyNeutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomyPostoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation.The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer.Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric AdenocarcinomaThe systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasisElevated neutrophil to lymphocyte ratio predicts mortality in medical inpatients with multiple chronic conditions.Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.A Prognostic Model Using Inflammation- and Nutrition-Based Scores in Patients With Metastatic Gastric Adenocarcinoma Treated With ChemotherapyPreoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
P2860
Q24568136-B95F58EF-7554-4730-89E6-DC551C6435E8Q26765926-3B8CE03A-F05A-43C7-9E6D-D1325051EE90Q27009534-35E23045-44E0-49C1-B4E9-31224657A5D7Q27022482-02847312-48A6-44AE-A019-27CA683E53B0Q28069360-1DB9ECB1-7463-460E-9C85-7F95A9A5A0ACQ31111026-8B850E1A-BB89-4DA6-982F-199EA4FFAFEDQ33697462-48117CA3-152B-4DAB-999C-D0889BE2CCC8Q33714143-1E532BA2-00FA-4206-90CE-C572EDBA67FAQ33762053-4DC334E9-113F-4CA0-8E37-4B7F11C459E7Q33912315-4FDB9700-2B66-4A27-A736-B310B146D96BQ34857119-7303BB96-B394-4E0B-A386-631FE40F44F3Q35128731-2340B8B1-ACF3-41FF-8D2C-061517442F8CQ35220302-5A0AD597-50A1-4684-AD24-A8DAB9C7306DQ35238082-2DE19FDE-ED65-4C0B-914E-3591C4B2E978Q35424504-050DEE25-5E1B-415A-94F9-B14B7B7DBCD9Q35534078-21780C2B-4B61-4986-989A-F365A797087FQ35594258-F944389B-20A3-49EF-BD8C-47D861ABC9CFQ35651537-885D5D43-BCF1-4407-ABBD-3725B090F917Q35766555-6F6C5CD1-BCC2-437F-9622-6768D27FFA60Q35839920-A0861F99-A232-4186-807A-043BB2C44939Q35925423-A2020714-6CF3-4946-8160-5C205154306CQ36023202-2F50A0FB-8456-4A89-93DF-05BDF4DE4155Q36069609-9EF71D16-B0C1-488D-9DF4-5A8BB6DC12FBQ36195847-AF1F0A36-AD3F-4456-8DB7-C24B7E41408EQ36303653-2272C679-A345-4710-9EF2-C59F297EAF6FQ36475957-3CC9E73B-3E7B-489E-9957-6FB8FB88E83DQ36544801-ADA69470-C687-49B1-BECC-E059529C8023Q36654421-1CEEA9CA-7218-4698-A47B-47354417A351Q36684702-A2324AAE-AA77-40CF-8795-250998BA36A4Q36749454-E1199ADD-ADEA-4B6B-9F6F-4910EDA67525Q36881262-B114F3E4-13F4-4793-8E13-2F90B8F756E0Q36905681-E0AA2A13-CBD1-4039-820F-6646043595A0Q36915015-46C63FBA-EB59-4A88-BB73-D0264DEE295DQ36999075-A96B9EAF-0F27-43E6-9F20-E83728A1B299Q37001415-4AFA80EA-E6B4-4B75-8EEB-A6013BE70BCBQ37003669-DD1533FF-7697-4878-8FDC-E9A85548F97EQ37040624-031F7BD2-9D4A-4B13-BAD6-3AA7E40D5B98Q37206464-75A69BCF-1DB8-466B-902E-A939E719CE76Q37206870-07F3CBED-16AE-45B5-A476-F3F4B43C972CQ37378328-4A83E762-FC4B-4AEC-B6A1-C6FE5A30559E
P2860
Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Elevated preoperative neutroph ...... in late stage gastric cancer.
@en
Elevated preoperative neutroph ...... in late stage gastric cancer.
@nl
type
label
Elevated preoperative neutroph ...... in late stage gastric cancer.
@en
Elevated preoperative neutroph ...... in late stage gastric cancer.
@nl
prefLabel
Elevated preoperative neutroph ...... in late stage gastric cancer.
@en
Elevated preoperative neutroph ...... in late stage gastric cancer.
@nl
P2093
P2860
P356
P1476
Elevated preoperative neutroph ...... in late stage gastric cancer.
@en
P2093
Dong Yi Kim
Jang Won Seon
Mi Ran Jung
Seong Yeob Ryu
Young Jin Kim
Young Kyu Park
P2860
P304
P356
10.1002/JSO.21986
P50
P577
2011-05-25T00:00:00Z